Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Hoping we get another PR

<< Previous

Bullboard Posts

Next >>

Comment by FredTheVoiceon Jan 12, 2021 7:53am

132 Views

Post# 32274074

RE:Hoping we get another PR

First time that I see you so Pis*?&% off SPCEO1.........and I've been here for a little time.....

Can you see some positive behind all emotion, dilution, and all thats been shared since yesterday ?

What is the pourcentage of the dilution of your faith about management this morning ?

Paul is the right guy like a lot seems to think ?

FTV.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China